The appearance of troglitazone, a potent antidiabetic agent, marked a significant chapter in the control of type 2 diabetes. However, its discontinuation from the market due to serious hepatotoxicity spurred https://inesrnfp547043.pointblog.net/troglitazone-and-related-thiazolidinediones-a-relative-overview-91902415